619 filings
Page 17 of 31
8-K
870rua1wz tqi1deso
22 Nov 11
Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors
12:00am
8-K
kh0u7z
21 Nov 11
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
12:00am
8-K
iius38 vqnogmg
14 Nov 11
Regulation FD Disclosure
12:00am
8-K
c2knavhxfiqtx
3 Nov 11
Regulation FD Disclosure
12:00am
8-K
fekomv
27 Oct 11
Regeneron Reports Third Quarter 2011 Financial and Operating Results
12:00am
8-K
ti7tr vfcw7
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
ehus1n
19 Oct 11
Other Events
12:00am
8-K
sl89bu2q91a2l ufp
18 Oct 11
Regeneron Pharmaceuticals Announces Proposed Offering of
12:00am
8-K
pad 5s21ms
26 Sep 11
Regulation FD Disclosure
12:00am
8-K/A
mg1d077r7n6qi0
15 Sep 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5drp d9ob
22 Aug 11
Regulation FD Disclosure
12:00am
8-K
672rtyx10s46jmbv 5y
17 Aug 11
Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
12:00am
8-K
dzr49ym11a
28 Jul 11
Results of Operations and Financial Condition
12:00am
8-K
rto3ixxmr
27 Jun 11
Regulation FD Disclosure
12:00am
8-K
ca7tvc5lqmkp
21 Jun 11
Other Events
12:00am
8-K
qncb6zgmvb dskh
15 Jun 11
Departure of Directors or Certain Officers
12:00am
S-8
w00q29ag3zi 750i7
13 Jun 11
Registration of securities for employees
12:00am
DEFA14A
gum b0amoudi3daado
1 Jun 11
Additional proxy soliciting materials
12:00am